Otsuka Medical Devices And Recor Medical Announce First FDA-Approved Renal Denervation System For Treatment Of Hypertension
07/11/2023 23:31
Nov 8 (Reuters) - Otsuka Holdings Co Ltd 4578.T :
* OTSUKA HOLDINGS CO LTD - OTSUKA MEDICAL DEVICES AND RECOR
MEDICAL ANNOUNCE FIRST FDA-APPROVED RENAL DENERVATION SYSTEM FOR
TREATMENT OF HYPERTENSION
Source text for Eikon: ID:nTSwg8e006
Further company coverage: 4578.T
Recent news on Otsuka Holdings
See all newsOtsuka, Ionis' experimental ALS drug meets main goal in late-stage study
Brief: Otsuka Pharmaceutical Announces Ulefnersen Early Access Program For Eligible People Living With FUS-ALS
Brief: Otsuka Pharmaceutical Says Phase 3 Fusion Results For Ulefnersen Met Primary Endpoint
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit In Rezilient3 Phase 3 Trial In First-Line Egfr Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Climb Bio rises after early-stage data for kidney disease drug